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Nt&ar magnetic nsmme (NMRJ iwbtp provides bii 
resolution tomographic bna#es that encompass the attire 
heart, enabling precise qmmtikation ofventriculsr volttmes 
and maas o-3,. Accurate mtaaurcmcnt~ of the -s oi 
i&wed by swell factors incktdbtg I) the stage of myo- 
cardial ildmzt evc&ttion (5): 2) the density of collateral 
NMR Inwing to cbnmctuire meioml edem that devdopa 
over several bourn when pwmeab%ty of micmvesselr 
cauw the extmvaatimt of plasma pm&ins and accumtda- 
tion of water G-10). In many cases, a m&ante increase in 
signal intensity of the itit m&t is diMctdt ta d&a 
bezuse of enhanced signal misb3g from chamber blood. In 
dogs, 4isuakatlo.~ of tbs iti rcgim i- genually not 
PMpible until at least 4 h at& conmary occhmim. when a 
measurable increase in tnmswrw relax&n time (TJ of 
infarcted myawdium occma [II). Beer et al. (12) shtdii 
serial chnnges in lmtgitudilral relaxation time (T,) v&es 
after mywadiaJ btfiwztica in humnns. An increwe in Tt wa 
found in the bVwct rc@on in abnwt all patients. However, 
Alterations in T, &aation time were not appreciable until 4 
days tier the mwt of camnary ecckoion. Therefore. the 
pmribility of reliab!c detection d the early phase of myn- 
cardial infarction by using NMR imaging aitbuut the admin- 
istmtion of contrast agent has been qxstioncd. At preres. 
etTm?n hnvc been directed toward rk earlier drtectinn of 
myocardial infarction. with better delinentian and contrn~. 
hv usine txuamaenetic 113.141 and suoemammaenetir: il51 
tiMR Gtitrast a&Is. Delineation of &cted m~wrdius 
after the administration of NMR contrast agents is also 
influenced by the time OT imaging aRcr inject& (7.8). Yost 
oftbe currsntlv availabk NMR cmwast aeeents cause siwsl 
enhmtcement prrdominantly in normal ~myocardium ;nd 
static blood adiacent o infarct regions (13.16): distinguishing 
between my&rdial infarct are~and tbe blood poaimay be 
pmbkmatic. Magnetic suxcptibiiity-enhancing agents and 
ruperparamag~tic agents resuh in zi@ rupprcssion in 
normal myowdium and static blood in the Idl vcntricul~ 
chamber but not in iahemic regions (14.151. Therefore. they 
provide dear and pemktent delincntian of regions with 
occlt!Ld vessels (14.15). 
Ik mechanism of signal supprrssion induced by dyspm- 
sium dtihyknctrkmine pmtaacetic acid-bkmethykmidc 
(DyDl’PA-BMA (g-043 Injection]). but not by supcrpara- 
agelnfrmnenerine~heia~llulnrspaceinrebionothmueh 
which it rsses (17). The feasibility of using DylYfPA-BMA 
for demarcatioo cf the area in jeqxmiy IW and for differ- 
entiation of occlusive and repaibsed mywudial infarctr 
(I of ihir agent Detemdnation of -the-lowest 
~ive~forpooduci~c*ardelk~~ofthciachemic 
or ittfated region fa P time sufficknt to acquire NMR 
Ns is a ptwquisite for clinical applications. 
ThnfotE, tlte specific aims of the culTen study were 
11 to d&e the IV/C! s&ctivc dose of DYDTFA-GA 
(s-043 Injectica) for delineadlg acutely i&xsd regions; 
and 2) to assrx.8 and co~xpare the timedewndmt recovery cd 
signal after intravenous i&&n ot di5erent &s of thk 
agent in nwmal and acutely infarcted myocardium. as well 
as skel*al muscle. 
M&OdS 
Nmhdc DylYlPA-BMA (S-043 laiecdon). Dysprosium 
diethylcnetriamitte pentaaeetic acid-bis-methylamide 
(DyDTPA-MA) is a nnnionic cbclate amtplw of dyspm- 
aium (so0 nut&liter), which is combined witb crdckm- 
sodkm-DTPA-BMA (25 mmoUttter) to Rum SM3 Injadon. 
289 m&l (S&tar/Sterling~~nthmpW&ed~. This agent 
was pr&tued by retltuing st&hiitric amounts of dy.spro. 
shun oxide and DTPA-BMA. A tidl descrip?ion tithe liittd 
and fbc compkx and their synthesis has been pHottsly 
reported (19). lhe agent ha5 low immediate systemic toxicity 
(nwdian lccbal dose [L&J 21.5 mmol/kgl Womaion pm- 
vi&d by Salwar) compared with that af gad&km chekte 
IGdDTPAI (LO* 6.0 mmovkgt when adminktend intwc- 
nously in mice 120). Approximately Hwb of this contrast 
wnl -\ cxcrvtrd by the kidnws within 24 h. Mediumterm 
&die% in mts. do& and monk& using multiple adminktm 
lions I IO injections over 21 days) of thir contrast medium at 
dnaes up 10 5 mmoUltg demonureted that lhe only renal 
eiTcct wu pmximal tubule vacuoktion. an observation also 
SCKI with hypcmsmolar schttions. The effect on hemmly- 
namicr HIIS cwaluated in anesthetized ogs i* doxs ofO.5. I 
and 1 mmolikg delivered 06 a bolus injection. A transient 
&creasc 15% to 15% of bsreline vx!ces) in awtic b!md 
pressure. kh ventricukr pressure and its tint derivative 
(dP/dTl and systemic vawlar resistace was observed M s 
after 0. I and 0.5 mmollkg of S-W3 In&&n. respwively. 
All hemod) namic variables retuned to baselirz !ivel within 
? to 3 min. ARcr the administration of the 2 mmolibg. dw 
cffcct un the precodinp hemodywnic vsrkbtcs was morr 
pmwmced. ranging between 21% and 40% (information 
pmvided by Salutar. data on file). This dae of 2 mm&g 
WI fourfold greater than the maximal dose used in tlte 
current study. The pksme h&life ol this agent is M min, 
and it is fontincd to innanscukr and cxtn~vasstir spaces. 
The doses used in the current study were 0.1, 0.3 and 
0.5 mm&g (2 n&kg volume i@cted over 36 to 45 s), which 
have biih safety inrkxrs of 21% 72 and 43. respectively. 
compared with the s&y index of 60 for *be clinkally 
approved dose (0.1 mmc&%g) of GdMPA. Using the samt 
animal m&l. a recent study indicated that slow injection 
I30 to 45 sI of I mmoL’!q &DyIYWA-BMA (%I43 Injaion) 
caused no signilkant ofrulses in bemt mte or mean arterial 
pressure Ii4). At present, 1~ datn mz avakbk regarding the 
e&t of thir conRust agent on serum bilirutin or imn kvek. 
sod the recommenrktkms of the Committcr on Animal 
ReKerch of tbk tmivemitx Sura~ue-Dawkv femnk i-a& 
hodi weight. At&Is were but&ted thmugb a cervical 
tmcheostomy and vendbated wbh a Harvard Apparatus 
mcknt respirator. The chest wra opened at the level dlhe 
Rwth intercostal rpaee sod the m&w branch of tbc kR 
camnnrv artery was cvxl&d near its origin kneath the kft 
atrial a&w&e. Rats were subjected to3 to 4 h ol perma- 
nent eomnary occlusion befac the awkition of the first 
NMR image.~Ckdusion of tbc left cokry anmy in tats 
pmdwz ixhemk In the am&or watt and parr Orlhe lateral 
wall ofthc kR ventricle. but M in the septum m posterior 
wall. The kR ju@dar vein was cannub~ted and used for 
administmtion 0fS-W It@.tion and supplemental doses of 
radium petttabarbitrd. 
A total of N) rats were used in the current study. 
Thiiy-onc surviving tats were mndomly ckssifKd into hwr 
~pr.AnimalsReti”ed0.1~n=8).0.3(n-8)w0~5b= 
0) mm&g of DyMPA-BMA or no wetrest medium (eon 
tml. n - 7). The cotmast agent was iajected slowly into the 
_itt&r vein over Xl to 45 s (1 injigtionlrat). Each animal 
received e single dase. The control gtwp underwent occlu- 
sion of the cotnary ariery; no placebo wes given before 
imaging The other 19 rets dkd of heart failure or ventrkular 
arrhythmia after occlusion of the 16 mmnery artery but 
bdore the administretion of the cotttmst agmt. 
AI the completion of each imaging pmtocol, the hearts 
were excised and sliced et the midvenuictdat level. The 
midventrictder sections (top and bottom surfsrcs) were 
steined with tti@unyltetremOttm chloride to metch the site 
end extent of the infarct m6kms noled w NMB imgee. Thie 
hiatocbemical dye (IS min ineubetion in 2% solution et 37p 
&fercted myocerdium remained wsteined 61). Stained se* 
dons we pbmo&mphed and compared with NMR imapcs. 
Tedttdcd verkbka tkr NMR ime&O. Elecbwa~ 
g?+ie (ECG) leads were inserted into the tight faelimb end 
lowu abdominal muscks of each ret and cottneeted to en 
RCG monitor (Acats~dL, Advanced Medical Resesrch) 
to provide R wave signals for njgserkg the NYR @se 
szquutce. This ECG si.qnal was cabined with a rerpimtory 
gale LO trig= the image pulse sequence. The tats were 
pIwed supine inside a S&m diameter birdcaOe ittte@nO 
coil. Acylindriedphslltomwarpmitionedadjacenttaeseh 
animal to enable stand* ofe&nel intensity fix smell 
chenOee in the rqxtitiat time dur@ the cane of the study. 
Im@es were ecqttired at 85.6 MHz witb a 2 T GE-CSl 
System equipped with Acutar S-150 self-shielded @kttt 
Foils (20 G/cm. ISem box we, GE Wdica.l System). Spin 
echo T+r&hted NMR ime& wiebks were echo deley 
time = 60 mr. nptitioe time = I.5 1, slice tbickeess = 
3 mm, hcld ofview = 60 x 60 mm. 128 pheseacoded steps. 
4 excitations/step and e block size d 512 cnnplcr data 
points. The ~&it@ circuit responded to every Ih R wwe. 
end a tti~ger delay of IO to I2 ms railer the R wave restdted 
in early systolk imaag becnuse the evexr@e RR interval in 
this pnimel model is betmen 250 and MO ms. The total 
acquisition time for eeeh imeg was I2 min. To lcate the 
beart, scout aaonel and tnneexiel ime6es wxe acquired. 
Beseline tmttsexial Trmightal imegs were obtained at the 
midvattticW level before the edministtiott of ccatttw 
agent, follmved by edminirtretion ot DyDTPA-BMA (Sat43 
Iniectimt). After iqkctkn of contrest medium, e total offour 
imaeeswaeaequindet5,20,OPnd60minto&te~ 
the rete of weskaet of this agent. 
@ml intensity values wue obtained from the idera 
tWkn (entemlateral wall), interventrkuler septum (tturmal 
myocerdium in this enimel modd), skeletel muscle (dorsal 
Sweti mwck of the beck) end oil phantom. ‘I& regions of 
interest wwe diitizcd by WblO ccutputerired pkmimetty. 
The camlinetes of eech n&m of intetest were fixed in tbe 
fvrt ime0e (5-mitt iw) after the edminiriretion of the 
fonlrasl @et6 and rent&d constent 6x analysis d the 
bnselitte and subrequent imlyg obtained after conttast 
medium iejeetion. The mageetie sweet&Sty &a of the 
three admitdstacd doses wa5 evebmted by conqmriag the 
n&at of interat signal intensity values in Trwei@tted 
NMR images obtained before and e&r cmttmst mdium 
iqkakn. Change in si@ intensity vetwe deech r@on of 
interest during the camme d 60 min were determined in all 
group. The times shown on the &s&se ofeeeh mph refer 
to the mid-pzint of each spin ccho ecquisition eyek. llte 
prceM s&al inbttaity (SI) c.batt,qe dcach region ofinterest 
was celculated usit@ the formula: 
%SIebang - 
St after eaitn# injedien 
SI befete metrest i&&e 
x 1%. 
The catthacl or aignel intensity ratio between normel end 
ittfucted myocardium wea cakuleted wit10 the equedmt: 
Myeardiel eatmet - 
SI of iefareted myowdiem 
Sl c#noneel myewdbee ’ 
Stalit.iiul a&air. Au numeric date were expressed es 
meen value * S6M. Time course ripPal intensity me- 
mettts (baseline image vs. image efter contrast medium 
injcctionat5,20,401ndMlmin~wwrUaae0mrarC(signal 
intettsityratio)changeeaRertheadmi&mticmofDyDTPA- 
BMA (S-043 1+&n) were evebmted by uein~ rqxeted 
meeswes analysis of veiieoce test (ANOVA) followed by 
theScheU6test.Thedegaof&elloseinducedbythe 
thne dosea d DyDTPA-BMA in the thtxe 6roups wes 
detemdned with P twteiid unpaired Studmt I test. Mean 
diiemnces in velue were deemed +&attt at p < 0.03. 
RemIt 
Si~oeliukrtdIybefereEDahlllabmlnJeetkn.Tbere 
wee P ei&5cant dilkrence io siyml intewity be+weea ncu. 
mal myocat’dium (0.46 f 0.03) and infarct atas (0.67 f 0.03) 
bdore the administration d DyDTPA-BMA (S.043 lqjew 
tiatj.Howewer,tbebotdersoftheiofaretamewereoot 
coneiatetttly demmcawd atthisstagcdmywardialinfud 
evdutim, 3 to 4 h &a kfl mmnuy arlery Llcchion @ii. 
I). In the eantml 9mu~. there wets tto sign&ant clmn6es in 
ei0ne.l itttenaity valuix of normal myocmdittm or infarct 
atessdttrit@tlteawseof60mbtofobeervation~kI). 
Signal inteatdty after eotttreet medium injeetioa. 
DyMl’A-BMA (SO43 lnjectknl at 0.1.0.3 ettd 0.3 q molikS 
pmdmxdae&tdfwtdeueeseins&~ittkttsityinttmmel 
myocedii. inpmved the eonspkuity and delieeetioe of 
ittfatcts and revealed smell infercts end thin walk that were 
notditTe.mntiakdfmmsuticchember bloodekngtheinfwet 
srear~thewalldthe~vcll(r*le~i~sobtsllled 
before contrast iqkctimt (Pi& 1). The -tie sw.aptiW 
ity e&a ~88 detected even et the 0.1 tmnabkg don by 
campdry &nnl intensity velues for the rc~ion dintaa in 
theTfl&btedittWlbd~anddle?CMttrprttWledinm 
iqiection. Dore-rrsponse awes were catstrttcted from tw 
dudions in s&nal intensity in response to intnvencus it&w 
lion d Q *hrec doses. Fiin~ IA shows a aerks of tan- 
axidimamdamtmbiectedto3hofkftcomttawatew 
occluskn-bdom and a& ($20 and w min) the ado;iais~ 
tion d 0.1 mmc#ks DYDTPA-MA. Immediatdv l.5 min) 
&er the admlnkmiiid0. I mmolkg, there ti a~si6ttitS 
cant decreass in signal intensity of nasally pcrfusai mye 
cardiim (6vm 0.46 * 0.03 to 0.29 2 0.0% 63 + 556 ut 
bpsdine *nal intensity values (p -z 0.05). However. llwe 
wu m pisnitkattt change in rifatal intensity of the intluct 
zone (bmm 0.67 = 0.03 tu 0.62 2 0.02) CMdc I). Maximal 
dim the ir&dim oi b.1 mmol& d DylYlW-SMA and 
persisted for at kast 20 min (Q. 9. Sii intatsiily values 
at 5 and 26 min werr statistkidty d&rent frcen ths bpoeline 
ri@nl itttettsity values. Subsequently. s&al intensity bqan 
to recover. This pattern d tiwt is closely related U, the 
pl~mh¶lf-litcdIhk~laJmil6.signrdinmmilyprrag 
time ah DymPA-BMA itlmim (wash-ill awl washm 
cmvm we shown io Pi 2 and T&k 1. 
F&~IBsbocustypicalNMRimqesinaz+tsnb&ted~ 
3hofkftcormPyMetyacltLsknbdoreatdafteftlte 
admirdstmtion dQ3 mmobk6 DyUl'PA-BjcA. Si@ &en- 
sityw~twhadto41~4%oCthebadincvalucUhI 
0.39 + 0.02 to 0.1.5 e 0.01) 5 min afks the iqkctkn of 
0.3mmolltb.anditpnLledbclowthc baselinvalucforat 
kast 60 min (p c 0.05) (FG. 2, Tabk I). Adminirtakn of 
DyDTPA-BMA at a dose of 0.3 mmdkg also msd ule 
inwavilarymsccniicmmofhi~h~d intaaity*cent 
totbeendaadialsmfaceaftheinfartrqimtforatlean 
26 r&n. However, tbenz will no a;Sni6wnt c&v in signal 
intensity of the idatzt r&on (from 0.57 f 0.03 to a49 t 
OM)durir~Ihe6Dminabsetvlltien~riod(FCg.3).BeePuse 
tbc signal immsity value at 60 min was s&ailicantl~ different 
from the bsseline~wdw (p < 0.03). a do& do.3 &ol&.g of 
DvLYl’PA-BMA caused Dersistmt demawaim of tk infara 
as a fbnction of time. 
Immediately (Emin image) atter tk administration of tk 
0.5 mmoUkg dose, DyDTPA-BMA produced a significantly 
greatw decrease in signal intensity (from 0.43 f 0.04 to 
0.12 f 0.01, 28 * 4% of tbe baseline value, p < 0.05). 
F@KC 2. bvluence of0.l (ct@l rut,,). 0.3 k&d rats, and 0.5 teigtu 
rats) mm&g dDyDTPA.BMA on myocardttl *ia, intenrity. The 
limes bkwn cm the aWa refer10 the midpaint ofesch lpin ccbo 
acquisition cycle. The reduction in signal. 8s well a~ the pmtstencc 
ddefmcaion, is dmc Cpfndslt. l p < 0.0s compared with wtuer 
cbtaincd before wmmst medium i+ction. tp < 0.M WKI “p < 0.W 
wmpwed ;vith values obtained after injccdm 010.1 mm&g. 0.3 
mm&k. rnpectircty, of DyDTFSBMA t.S+W tnjoxion~. 
campored with that produced by the 0.1 and 0.3 mm&g 
doses (Fig. 2). The washout of this dose was also incomplete 
at M) min: however. tkre was no signfiant ditTermce in tk 
washout (recovery of signal intensity) between the 0.E aad 
OS-mmoltkg doses. At the 05mmollk,g dose, DyDTpA- 
BMA ccu&tdy erased tk inttacwitary erescentic area of 
hii signal intensity adjacent to tk endocdrdiat surface of 
the intlrct mm (Fit IC). No significant cbmges were 
obsened in signal i!!Imsity of tk infarct region after the 
sdministratim of tbis don (Fig. 3. Table I). 
pit 4 demmutmtg tk absence 19 any signtticm~ 
change in signal intensity rdios during the course of the 
6hmln observation period in the control group. !t alsc shox. 
the dfective contrast enhancement expressed as s&d in- 
tmsity rstiDI bchveen bxfxckd mtd nmmal mywmdium 
after the admbd&ation af 0.1, 0.3 and 0.5 mm&g ci 
DyDTPA-BMA. B&we the admbdrtmtion of the contrmt 
qteat. there was no signi6cant diince in signnl intensity 
ratio8 among the four m”Ps. However, there was a sigaif- 
icant diffauw ia sipaal imensity ratios nor at least 5 mia 
after the admiaisuatiin of 0.1 tamal& of DyDTPA-LtMA. 
At 0.3 aad 0.5 q moVI& @aI bttcasity ratios were sigdti- 
caatly~randpersistedforalmgerpti(2Oand 
4 min. rrrpecttvety~ ccmt,rxu.l with camul gnwp values. 
Tbedeaea~eins&matintensityd&eletalmuscleusr 
rigr&a@ less than that in normal myowdiw at all 
doses.S&tallosswasawdcmteindegmeaadwasdose 
dependant IFi&. 5, Tabk 1). A dose of 0.1 maw&g 
fJyUlFA.BMA FWJIIC~ tmnsknt rignal bxs (for S min 
oaly)folbwed byeompkterecowyofthesigaal. Ttteeticct 
was mom pronounced aad persisted bm~r tfm 60 min; afta 
the admbdstmtton do.3 and 0.5 uw&lzg. 
P&ma&m Emt@~ Portmcmem evaluation of hir- 
tocbemic8lly stained myowdial rlicer verified the presence 
aad locatkm of tlte iafarct trgion depicted m NMR bnagar. 
ltteachcuc,tbe~dmywa&lregioawaslocatcdia 
tbeMaiwsDd~ofthlatcralwallaof~beMvenviele 
aad axwpomkd to the inlant m&it demtucated by 
DyDl’PA-BMA-eabaaccd NfdJt imspes. 
si&y demo&ate that %ima&k after DyDTPA-BMA 
CWl3 Iaiection) can rsdily idemif~ the reaim~ of acutely 
inlarctcd~myccxdkm at aosCs c&pa& to tbc-se dr 
T,-zmbanciaa ageats. At bw doses [al to 05 mm&k& 
DyDTPA-BMA siga%tcantty improved the coatmst dit%r- 
aces behveen aotmally per&d mywa&tm wtd te&ions 
with acute iat%ctim. The set effect of DyDTPA-BMA on 
myowdii aad skdetal mwcle rigad ws dose depndmt. 
AdmedO.lrpmdllypmdueedtranr*ldwamtkmd 
tbeinfarctloneardconldbewedforimmcdtatebnaaiuz 
after btiection. Because signat imemity hd almost c& 
pletelyreuwmdby4Ombt.thisdosewnddbeuKdif 
multiple ia&tionr mrc needed to evaluate an tatuwmiaa. 
A dose ofO.3 mm&kg pmvided pcnirtem ddincation ofthe 
iat&tregion.rewb&iuatoagimag@wtndpw. Satined 
signal lolr of perfnsed myocaniium WBI also obtained by 
adminirterina 0.5 mmd/ka of DyDTPA-BMA. llte lack cd 
si&icrmtcl&esinsig&li&tyafmnaatandir&& 
myocaidium ia the wmml gmq (no con- medium) 
duriag the ahserva& period indicates that the cbaages 
obSerwt?+reauruabk btheSW@bttttyefPect0f 
DVDTPA-BMA. 
wVilhiager et al. (II) found ia rat brain that induction of 
diieantial contrast by magnetic wcept~%ilityenhP 
wats required a relatively Iti& dase. However, mu study 
ia atywditatt ssgcsu that dases of9yyDTpA-BMA W43 
Iqiectiool comppmbk to those used for T,-enhanciy agents 
(16,z2,23) can Pmvtde s4funt diEererltial cosuast, nlc 
patency ofthis agent in the myocardium can be ettributed to 
its rapid entry into the extmwseuler space. the high cqil- 
lery dettsity of myocadium end the let’ge magnetic moment 
of dysprosium (IO.6 EM). 
The new nanionic magnetic susceptibility-enhancing 
agent, WDTPA-BMA (SCM3 I@ction), provides several 
unique advantages as P contrast agent fbr NMR imaging of 
the heart. It has proved effective for detecting the area in 
jeqady after brief occlusion ofthe coronary artery (14) and 
fordifferentktioz! of occlusive and tqwfured acute myocar- 
dial ittfkcts (IO. The absence of any significant changes in 
heart rate and systemic stterkl blood prersere ti its 
edministmtioe et e nletively high dose (I mm&g) in rats 
subjected to acute ischemia as well as the high LD, in mice 
(21.5 mmolcg) indicates that this ewt should be safe for 
use in patients with acute myocardird infarction. However. 
our results were obtained in anesthetized animalr under 
umtmlkd conditions; therefore, extrapolation of these flnd- 
ings directly to patients with acute myocardkl infat&m 
requires caution. The clinical applicability of this new an- 
hast ageot in the deteftion of acute- myocardial infarction 
has yes to be detemtined. 
Meclunkm of action. The mechanism of ectiott of 
DyDTPA-BMA is Mmwtt from that of the NMR metrest 
media currently in clieical use, which m T,-eohencing 
tt&nt efter the edminietrkion of DGDTPA is derived fran 
regicmel changes in megnetic susceptibility resulting from 
the diti%sion cd water. Accordingly. it has been postuleted 
tbet the primmy mechenism of action of dysprosium is 
dif&sion-induced sqin de@@, resultin in e Lola of phase 
coherence OfneerbY mIlb3ns (17.24). 
The current st& bhdml&&t of NMR imaging does 
no1 allow the depiction of ischemic or acutely infated 
myoxdium in the early phases after coronary occlusion. 
However, delineation of ischemic or irdarn tzgiotts within 
the Rmt few iwus after comtwy a~~.Iusion has been possi- 
ble with the use of pammagwtic wttttat media (14.24). 
SPectmmetiic measurements of excised myacprdium (with- 
out the admi&mtion of NMR contrast medii have dem- 
onstrated small changes in T, after3 b ofacute ischemia with 
relatively smaller changes in T, (6). In view of these limited 
changes in T, and T2, NMR contrast medk arc likely to pky 
a major mk in the demarcation of isclxmic regions by 
enhancing differences in both T, and T> 
Previous studies in dogs have shwm that NMR imaging 
can detect regions of myocardiaf infpretion on the basis of 
changes in tissue rekxation times C25,26), which BR pmba- 
bly related to hweases in myowdkl water content (27). In 
a dog model with 3 to 4 h of left comnary artery occltion, 
hnseline images showed si@crmt diffaenccs in signal 
intensity between normal and infarcted myocardium. The 
elevated signal observed on T+veighted images in this early 
&edema itt the isch&ic t&on. kowew. chant&in tissue 
water in acute infsretion, althcqh ptwnt, are less promi- 
nent. Weismen et al. (28) repmted thet the cvoh~tion of 
of that in humans. 
The magnitude of signal loss in skektai musck was 
rignifl~rdly smnller than that observed in cardkc muck al 
ail administered doses. This finding is consistent with previ- 
0~s studies using T,-enhanciee and meenetic susceotibility- 
enhancing a& (jJ3.14). The diire~ce in mha;rem&t 
of thex two rebions may he attrihutcd to waal feMr& 
including cap&y density. blood flow, tissue blood ~lttme 
and size of the exbaceUullar space. 
Cawlttsk~. By providino clear delineation between nor- 
mal snd inhreted myocadium, low daer Or DyDTPA-BbI.4 
d NMR 
ittfbrction. Early detection of myowdial infarcts is likely to 
have value in Buidittg thaapy and in cvaluatin~ various 
~armacolagic intetvmtions used to lhnit infarct size. 
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